Background: Intrauterine fetal death (IUFD) is a cataclysmic event for the parents. It is an important indicator of maternal and perinatal health of a given population. This study was undertaken to study the maternal and fetal factors associated with IUFD. Methods: This was a retrospective study carried out in Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) General Hospital, Dhaka, from November 2019 to October 2020 . The details of history, examination findings, investigation reports , mode of delivery and fetal outcome were obtained from records. Results: A total number of 57 intrauterine fetal death were reported amongst 1534 deliveries conducted during the study period. The occurrence of intrauterine fetal death was 37.1/1,000 live births ; Among all these intrauterine fetal death cases, 87.7% deliveries were preterm and 89.4% deliveries were singleton delivery. The other associated maternal conditions were uncontrolled blood glucose in 64.9% cases, hypertensive disorders in 36.8% cases, other medical causes in 10.5% cases. Associated fetal conditions included intrauterine growth retardation of fetus in 28.0% cases, oligohydramnios in 21.0% cases, congenital malformation in 14.0 % cases. Placental condition included antepartum hemorrhage in 3.5% cases. Conclusions: In this study, the occurrence of intrauterine fetal death was associated with high incidence of uncontrolled blood glucose, oligohydramnios and congenital malformations . This emphases the importance of proper antenatal care and identification of risk factors and its proper treatment. BIRDEM Med J 2023; 13(2): 88-91
Background & objectives: Postmenopausal bleeding is frequent in gynecology and occurs approximately in 5% to 10 % of postmenopausal women. About 10% women with postmenopausal bleeding have a primary or secondary malignancy. Common malignancies among them are endometrial or cervical carcinoma and rarely, ovarian cancer. The incidence of malignancy in postmenopausal period remains sufficiently high, so it requires immediate investigations for early diagnosis, prompt treatment and vigilant follow up. The objective of the present study is to evaluate the causes of postmenopausal bleeding based on histopathology of endometrium and the percentage of various benign, premalignant and malignant lesions in patients with post-menopausal bleeding. Methods: A retrospective study was undertaken on 78 women presenting with postmenopausal bleeding in Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic disorders (BIRDEM) Hospital, Dhaka, from July 2018 to June 2019. Histopathological reports and patient’s profile were reviewed. Causes of bleeding were identified and related to patients’ age. Results: Among of 78 cases of postmenopausal bleeding, we found 8 cases of cancer (10.26%). Among them 2 cases were cancer of uterine cervix and 6 cases were cancer of uterine corpus. Benign pathology was more frequent (63 cases: 80.77%), essentially presented with endometrial hyperplasia without atypia 20.52% cases, endometrial polyp 16.67% cases, cervical polyp 14.11% cases, leiomyoma found in 9% cases and preinvasive disease about 9% cases. Histopathological findings in 2 cases of carcinoma cervix were invasive squamous cell carcinoma and 6 cases of endometrial cancer were endometrial adenocarcinoma. Cancer increased with increasing age while the incidence of bleeding decreased with age. Conclusion: Despite the fact that benign pathology is more frequent than malignancy as a cause of postmenopausal bleeding, we must always rule out a cancer by endometrial and cervical biopsy. Bangladesh J Obstet Gynaecol, 2020; Vol. 35(2): 112-116
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.